Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers
Authors:
Open Access
- 6 August 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 29 (11) , 2120-2125
Abstract
Because p53 and p73 are associated with critical cellular processes and can be inactivated or degraded by the human papillomavirus (HPV) E6 oncoprotein, we investigated the combined effects of p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer. We analyzed genotype data from 326 patients with squamous cell carcinoma of the oral cavity or oropharynx and 349 cancer-free controls. We found that HPV16 seropositivity was associated with an increased risk of oral cancer [adjusted odds ratio (OR), 3.42; 95% confidence interval (CI), 2.28–5.13], especially among never-smokers (adjusted OR, 8.20; 95% CI, 3.66–18.4) and subjects with variant genotypes [adjusted OR for p53 Arg/Pro + Pro/Pro (Pro carriers), 5.00; 95% CI, 2.72–9.21; adjusted OR for p73 GC/AT + AT/AT (AT carriers), 3.83; 95% CI, 1.98–7.41]. HPV16 seropositivity was also associated with an significantly increased risk of oral cancer in all three risk groups with combined genotypes [adjusted ORs (95% CIs) were 2.28 (1.15–4.54) for p53 Arg/Arg and p73 GC/GC, the low-risk group; 3.97 (2.14–7.36) for p53 Arg/Arg and p73 AT carriers or p53 Pro carriers and p73 GC/GC, the medium-risk group and 5.11 (2.00–13.0) for p53 Pro carriers and p73 AT carriers, the high-risk group]. Moreover, HPV16-seropositive never-smokers in the high-risk group exhibited an ∼11-fold greater risk of oral cancer (adjusted OR, 11.3; 95% CI, 1.22–106.0) than did HPV16-seronegative never-smokers in the low-risk group. These findings suggest that the combined variants of p53 and p73 significantly increase the risk of HPV16-associated oral cancer, especially among never-smokers.Keywords
This publication has 58 references indexed in Scilit:
- p73: Friend or foe in tumorigenesisNature Reviews Cancer, 2002
- p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and EthnicityJNCI: Journal of the National Cancer Institute, 2002
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002
- Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteinsInternational Journal of Cancer, 2001
- A possible role of p73 on the modulation of p53 level through MDM2.2001
- Surfing the p53 networkNature, 2000
- Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck CancersJNCI: Journal of the National Cancer Institute, 2000
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Cell, 1990
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990